The group’s principal activity is to provide reproductive health business. The group’s services include collection, testing, processing and storage of umbilical cord blood stem cells. The group products sold under the trade names ViaCell(R) and ViaCord(R). The group operates from the United States, Germany and Singapore. Of the total revenue in the year 2006, the United States accounted for $54,136and Singapore $290 (thousands).
Executive Information
Name
Title
Email
Vaughn Kailian
Chmn.
N/A
Jim Corbett
Pres. - Viacell Reproductive Health
N/A
John Thero
Sr. VP - Finance, CFO
N/A
Morey Kraus
CTO
N/A
Anne Cook
General Counsel, Sr. VP - Business, Corporate Development
